Conference Series organizes a conferences of 3000+ Global Events inclusive of 600+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 70000 eminent personalities, reputed scientists as editorial board members.
Conference Series LLC LTD invites all the participants across the globe to attend the “Contemporary researches in Haematology and Oncology”
13th World Congress on Haematology and Oncology" (World Haematology 2019) conveys recent discoveries and developments in blood disorders and cancers. A complete knowledge of a scientific discipline that described and explores the use of testing, extraction and Devices in industry as well as healthcare markets.
World Haematology 2019 provides the importance of Blood and Disorders. Hematology is the study of blood in health and disease. It includes problems with the red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting (hemostasis and thrombosis). A hematologist is a medical doctor who applies this specialized knowledge to treat patients with blood conditions. Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets. Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. They can be acute or chronic. Many blood disorders are inherited. Other causes include other diseases, side effects of medicines, and a lack of certain nutrients in your diet. People may be affected by many different types of blood conditions and blood cancers. Common blood disorders include anemia, bleeding disorders such as hemophilia, blood clots, and blood cancers such as leukemia, lymphoma, and myeloma.
Approximately every 3 minutes one person is diagnosed with a blood cancer. An estimated combined total of 174,250 people are expected to be diagnosed with leukemia, lymphoma or myeloma in 2018. New cases of leukemia, lymphoma and myeloma are expected to account for 10 percent of the estimated 1,735,350 new cancer cases diagnosed in the in 2018.
- Blood Disorders
- Hematological Oncology
- Blood Transfusion
- Stem cell Research
- Blood Tests
- Multiple Myeloma
- Pediatric Hematology
- Veterinary Hematology
- Biomarkers in Hematology
- Hematological malignancies
- Management of Hematologic Emergencies
- New Drug Discovery in Hematology
- Case reports and Epidemiology of Hematology & Hem-Oncology
- Hematology & Oncology Nursing
- Transfusion Medicine and Hematology Research
- All accepted abstracts will be published in respective Supporting International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at:- https://hematology.global-summit.com/